No child left behind in SDHB testing for paragangliomas and pheochromocytomas

Journal of Clinical Oncology

Volumn 29, Issue 31, 2011, Pages 4070-4072

  Schiffman, Joshua D ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 6 FLUORODOPAMINE F 18; CATECHOLAMINE; CHROMOGRANIN A; FLUORODEOXYGLUCOSE F 18; HYPOXIA INDUCIBLE FACTOR 1; MISMATCH REPAIR PROTEIN PMS2; NORADRENALIN; NORMETADRENALIN; PROTEIN MSH2; SUCCINATE DEHYDROGENASE;

ANGIOGENESIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL RESPIRATION; CHONDROMA; COLORECTAL CANCER; EDITORIAL; FAMILIAL CANCER; GENE MUTATION; GENETIC SCREENING; GLUCOSE TRANSPORT; GLYCOLYSIS; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; METASTASIS; MITOCHONDRIAL RESPIRATION; MORBIDITY; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; OXYGEN SENSING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; THYROID CANCER; TUMOR GROWTH;

ADRENAL GLAND NEOPLASMS; FEMALE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; MALE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SUCCINATE DEHYDROGENASE;

EID: 80755167876     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.8695     Document Type: Editorial

References (27)

1. Warburg O: On the origin of cancer cells. Science 123:309-314, 1956
2. Hensen EF, Bayley JP: Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma. Fam Cancer 10:355-363, 2011
3. Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, et al.: Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer 16: 391-400, 2009
4. Rutter J, Winge DR, Schiffman JD: Succinate dehydrogenase - Assembly, regulation and role in human disease. Mitochondrion 10:393-401, 2010
5. Bayley JP, Devilee P: Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? Curr Opin Genet Dev 20:324-329, 2010
6. Hao HX, Khalimonchuk O, Schraders M, et al.: SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325:1139-1142, 2009
7. Ricketts CJ, Forman JR, Rattenberry E, et al.: Tumor risks and genotype-phenotype- proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31:41-51, 2010
8. Boedeker CC, Neumann HP, Maier W, et al.: Malignant head and neck paragangliomas in SDHB mutation carriers. Otolaryngol Head Neck Surg 137: 126-129, 2007 (Pubitemid 46962136)
9. Boedeker CC, Neumann HP, Offergeld C, et al.: Clinical features of paraganglioma syndromes. Skull Base 19:17-25, 2009
10. Neumann HP, Pawlu C, Peczkowska M, et al.: Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943-951, 2004 (Pubitemid 39097204)
11. Cascón A, Landa I, López-Jiménez E, et al.: Molecular characterisation of a common SDHB deletion in paraganglioma patients. J Med Genet 45:233-238, 2008 (Pubitemid 351518729)
12. Neumann HP, Bausch B, McWhinney SR, et al.: Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459-1466, 2002 (Pubitemid 34755714)
13. Drovdlic CM, Myers EN, Peters JA, et al.: Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope 111:1822-1827, 2001 (Pubitemid 32946461)
14. King KS, Prodanov T, Kantorovich V, et al.: Metastatic pheochromocytoma/ paraganglioma related to primary tumor development in childhood or adolescence: Significant link to SDHB mutations. J Clin Oncol 29:4137-4142, 2011
15. Brouwers FM, Eisenhofer G, Tao JJ, et al.: High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: Implications for genetic testing. J Clin Endocrinol Metab 91:4505-4509, 2006 (Pubitemid 44833431)
16. Timmers HJ, Kozupa A, Eisenhofer G, et al.: Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 92:779-786, 2007 (Pubitemid 46465640)
17. Villani A, Tabori U, Schiffman J, et al.: Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: A prospective observational study. Lancet Oncol 12:559-567, 2011
18. Janeway KA, Kim SY, Lodish M, et al.: Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci U S A 108:314-318, 2011
19. van Nederveen FH, Gaal J, Favier J, et al.: An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: A retrospective and prospective analysis. Lancet Oncol 10:764-771, 2009
20. Douwes Dekker PB, Hogendoorn PC, Kuipers-Dijkshoorn N, et al.: SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J Pathol 201:480-486, 2003 (Pubitemid 37408270)
21. Gill AJ, Benn DE, Chou A, et al.: Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol 41:805-814, 2010
22. Gill AJ, Chou A, Vilain R, et al.: Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol 34:636-644, 2010
23. Mvundura M, Grosse SD, Hampel H, et al.: The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med 12:93-104, 2010
24. Hall G, Clarkson A, Shi A, et al.: Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma. Pathology 42:409-413, 2010
25. Shia J, Tang LH, Vakiani E, et al.: Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: A 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol 33:1639-1645, 2009
26. Hampel H, Frankel WL, Martin E, et al.: Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26:5783-5788, 2008
27. Hampel H, Frankel WL, Martin E, et al.: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851-1860, 2005